|
1
|
Jelovac D and Armstrong DK: Recent progress in the diagnosis and treatment of ovarian cancer. CA Cancer J Clin. 61:183–203. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jacobs IJ, Menon U, Ryan A, Gentry-Maharaj A, Burnell M, Kalsi JK, Amso NN, Apostolidou S, Benjamin E, Cruickshank D, et al: Ovarian cancer screening and mortality in the UK collaborative trial of ovarian cancer screening (UKCTOCS): A randomised controlled trial. Lancet. 387:945–956. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cho KR and Shih IeM: Ovarian cancer. Annu Rev Pathol. 4:287–313. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bookman MA: Standard treatment in advanced ovarian cancer in 2005: The state of the art. Int J Gynecol Cancer. 15 (Suppl 3):S212–S220. 2005. View Article : Google Scholar
|
|
5
|
Stipp CS, Kolesnikova TV and Hemler ME: Functional domains in tetraspanin proteins. Trends Biochem Sci. 28:106–112. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sciuto TE, Merley A, Lin CI, Richardson D, Liu Y, Li D, Dvorak AM, Dvorak HF and Jaminet SC: Intracellular distribution of TM4SF1 and internalization of TM4SF1-antibody complex in vascular endothelial cells. Biochem Biophys Res Commun. 465:338–343. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hemler ME: Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu Rev Cell Dev Biol. 19:397–422. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xing P, Dong H, Liu Q, Zhao T, Yao F, Xu Y, Chen B, Zheng X, Wu Y, Jin F and Li J: Upregulation of transmembrane 4 L6 family member 1 predicts poor prognosis in invasive breast cancer: A STROBE-compliant article. Medicine (Baltimore). 96:e94762017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Park YR, Lee ST, Kim SL, Liu YC, Lee MR, Shin JH, Seo SY, Kim SH, Kim IH, Lee SO and Kim SW: MicroRNA-9 suppresses cell migration and invasion through downregulation of TM4SF1 in colorectal cancer. Int J Oncol. 48:2135–2143. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cao R, Wang G, Qian K, Chen L, Ju L, Qian G, Wu CL, Dan HC, Jiang W, Wu M, et al: TM4SF1 regulates apoptosis, cell cycle and ROS metabolism via the PPARү-SIRT1 feedback loop in human bladder cancer cells. Cancer Lett. 414:278–293. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cao J, Yang JC, Ramachandran V, Arumugam T, Deng DF, Li ZS, Xu LM and Logsdon CD: TM4SF1 regulates pancreatic cancer migration and invasion in vitro and in vivo. Cell Physiol Biochem. 39:740–750. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vogel W, Gish GD, Alves F and Pawson T: The discoidin domain receptor tyrosine kinases are activated by collagen. Mol Cell. 1:13–23. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Peretti M, Badaoui M, Girault A, Van Gulick L, Mabille MP, Tebbakha R, Sevestre H, Morjani H and Ouadid-Ahidouch H: Original association of ion transporters mediates the ECM-induced breast cancer cell survival: Kv10.1-Orai1-SPCA2 partnership. Sci Rep. 9:11752019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang SH, Baek HA, Lee HJ, Park HS, Jang KY, Kang MJ, Lee DG, Lee YC, Moon WS and Chung MJ: Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung carcinomas. Oncol Rep. 24:311–319. 2010.PubMed/NCBI
|
|
15
|
Hu Y, Liu J, Jiang B, Chen J, Fu Z, Bai F, Jiang J and Tang Z: MiR-199a-5p loss up-regulated DDR1 aggravated colorectal cancer by activating epithelial-to-mesenchymal transition related signaling. Dig Dis Sci. 59:2163–2172. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jin H, Ham IH, Oh HJ, Bae CA, Lee D, Kim YB, Son SY, Chwae YJ, Han SU, Brekken RA and Hur H: Inhibition of discoidin domain receptor 1 prevents stroma-induced peritoneal metastasis in gastric carcinoma. Mol Cancer Res. 16:1590–1600. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gadiya M and Chakraborty G: Signaling by discoidin domain receptor 1 in cancer metastasis. Cell Adh Migr. 12:315–323. 2018.PubMed/NCBI
|
|
18
|
Gao H, Chakraborty G, Zhang Z, Akalay I, Gadiya M, Gao Y, Sinha S, Hu J, Jiang C, Akram M, et al: Multi-organ site metastatic reactivation mediated by non-canonical discoidin domain receptor 1 signaling. Cell. 166:47–62. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Prat J: Ovarian, fallopian tube and peritoneal cancer staging: Rationale and explanation of new FIGO staging 2013. Best Pract Res Clin Obstet Gynaecol. 29:858–869. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stierer M, Rosen H, Weber R, Hanak H, Spona J and Tuchler H: Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factors. Ann Surg. 218:13–21. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tang Z, Li C, Kang B, Gao G, Li C and Zhang Z: GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45((W1)): W98–W102. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM: Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci USA. 101:9309–9314. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, Briggs BB, Barrette TR, Anstet MJ, Kincead-Beal C, Kulkarni P, et al: Oncomine 3.0: Genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia. 9:166–180. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P, et al: STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47((D1)): D607–D613. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu G, Wang LG, Han Y and He QY: ClusterProfiler: An R package for comparing biological themes among gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qiu Y, Pu C, Li Y and Qi B: Construction of a circRNA-miRNA-mRNA network based on competitive endogenous RNA reveals the function of circRNAs in osteosarcoma. Cancer Cell Int. 20:482020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gyorffy B, Lanczky A and Szallasi Z: Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients. Endocr Relat Cancer. 19:197–208. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lin SI, Huang MH, Chang YW, Chen IH, Roffler S, Chen BM, Sher YP and Liu SJ: Chimeric peptide containing both B and T cells epitope of tumor-associated antigen L6 enhances anti-tumor effects in HLA-A2 transgenic mice. Cancer Lett. 377:126–133. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gao C, Yao H, Liu H, Feng Y and Yang Z: TM4SF1 is a potential target for anti-invasion and metastasis in ovarian cancer. BMC Cancer. 19:2372019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yeh YC, Lin HH and Tang MJ: Dichotomy of the function of DDR1 in cells and disease progression. Biochim Biophys Acta Mol Cell Res. 1866:1184732019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Quan J, Yahata T, Adachi S, Yoshihara K and Tanaka K: Identification of receptor tyrosine kinase, discoidin domain receptor 1 (DDR1), as a potential biomarker for serous ovarian cancer. Int J Mol Sci. 12:971–982. 2011. View Article : Google Scholar : PubMed/NCBI
|
